These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26138747)
1. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas. Cui C; Lu Z; Yang L; Gao Y; Liu W; Gu L; Yang C; Wilson J; Zhang Z; Xing B; Deng D; Sun ZS Mol Carcinog; 2016 Jul; 55(7):1163-74. PubMed ID: 26138747 [TBL] [Abstract][Full Text] [Related]
2. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas. Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577 [TBL] [Abstract][Full Text] [Related]
3. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma. Zhang T; Cao C; Wu D; Liu L Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735 [TBL] [Abstract][Full Text] [Related]
4. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma. Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874 [TBL] [Abstract][Full Text] [Related]
5. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
6. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes. Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670 [TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. Kanda M; Sugimoto H; Kodera Y World J Gastroenterol; 2015 Oct; 21(37):10584-97. PubMed ID: 26457018 [TBL] [Abstract][Full Text] [Related]
8. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma. Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236 [TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation. Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221 [TBL] [Abstract][Full Text] [Related]
10. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection. Liu ZJ; Huang Y; Wei L; He JY; Liu QY; Yu XQ; Li ZL; Zhang J; Li B; Sun CJ; Liang WB; Sun AM; Qin Y Neoplasma; 2017; 64(5):795-802. PubMed ID: 28592132 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma. Peng W; Fan H Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684 [TBL] [Abstract][Full Text] [Related]
14. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related]
15. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas. Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893 [TBL] [Abstract][Full Text] [Related]
16. Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features. Malouf GG; Tahara T; Paradis V; Fabre M; Guettier C; Yamazaki J; Long H; Lu Y; Raynal NJ; Jelinek J; Mouawad R; Khayat D; Brugières L; Raymond E; Issa JP Epigenetics; 2015; 10(9):872-81. PubMed ID: 26224146 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma. Arai E; Ushijima S; Gotoh M; Ojima H; Kosuge T; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y Int J Cancer; 2009 Dec; 125(12):2854-62. PubMed ID: 19569176 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. Shitani M; Sasaki S; Akutsu N; Takagi H; Suzuki H; Nojima M; Yamamoto H; Tokino T; Hirata K; Imai K; Toyota M; Shinomura Y Tumour Biol; 2012 Oct; 33(5):1307-17. PubMed ID: 22457049 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma. Yuan SX; Zhang J; Xu QG; Yang Y; Zhou WP Cancer Lett; 2016 Sep; 379(2):239-44. PubMed ID: 26282784 [TBL] [Abstract][Full Text] [Related]
20. Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma. Zhu C; Utsunomiya T; Ikemoto T; Yamada S; Morine Y; Imura S; Arakawa Y; Takasu C; Ishikawa D; Imoto I; Shimada M Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S729-35. PubMed ID: 24992910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]